XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Supplemental Condensed Consolidating Financial Information | 9 Months Ended
--- | ---
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Supplemental Condensed Consolidating Financial Information | NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION During December 2012, HCA Healthcare, Inc. issued $1.000 billion aggregate principal amount of 6.250% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries. HCA Inc., a direct wholly-owned subsidiary of HCA Healthcare, Inc., is the obligor under a significant portion of our other indebtedness, including our senior secured credit facilities, senior secured notes and senior unsecured notes (other than the senior unsecured notes issued by HCA Healthcare, Inc.). The senior secured notes and senior unsecured notes issued by HCA Inc. are fully and unconditionally guaranteed by HCA Healthcare, Inc. The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, 100% owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility). Our summarized condensed consolidating comprehensive income statements for the quarters and nine months ended September 30, 2018 and 2017, condensed consolidating balance sheets at September 30, 2018 and December 31, 2017 and condensed consolidating statements of cash flows for the nine months ended September 30, 2018 and 2017, segregating HCA Healthcare, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow: HCA HEALTHCARE, INC. CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT FOR THE QUARTER ENDED SEPTEMBER 30, 2018 (Dollars in millions)
|  | HCA Healthcare, Inc. Issuer |  |  | HCA Inc. Issuer |  |  | Subsidiary Guarantors |  |  | Subsidiary Non- Guarantors |  |  | Eliminations |  |  | Condensed Consolidated |
Revenues |  | $ | — |  |  | $ | — |  |  | $ | 6,747 |  |  | $ | 4,704 |  |  | $ | — |  |  | $ | 11,451 |
Salaries and benefits |  |  | — |  |  |  | — |  |  |  | 3,090 |  |  |  | 2,287 |  |  |  | — |  |  |  | 5,377 |
Supplies |  |  | — |  |  |  | — |  |  |  | 1,115 |  |  |  | 775 |  |  |  | — |  |  |  | 1,890 |
Other operating expenses |  |  | 2 |  |  |  | — |  |  |  | 1,137 |  |  |  | 958 |  |  |  | — |  |  |  | 2,097 |
Equity in earnings of affiliates |  |  | (728 | ) |  |  | — |  |  |  | (2 | ) |  |  | (7 | ) |  |  | 728 |  |  |  | (9 | )
Depreciation and amortization |  |  | — |  |  |  | — |  |  |  | 340 |  |  |  | 242 |  |  |  | — |  |  |  | 582 |
Interest expense (income) |  |  | 16 |  |  |  | 913 |  |  |  | (423 | ) |  |  | (64 | ) |  |  | — |  |  |  | 442 |
Losses (gains) on sales of facilities |  |  | — |  |  |  | — |  |  |  | (6 | ) |  |  | — |  |  |  | — |  |  |  | (6 | )
Losses on retirement of debt |  |  | — |  |  |  | 9 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 9 |
Management fees |  |  | — |  |  |  | — |  |  |  | (158 | ) |  |  | 158 |  |  |  | — |  |  |  | — |
|  |  | (710 | ) |  |  | 922 |  |  |  | 5,093 |  |  |  | 4,349 |  |  |  | 728 |  |  |  | 10,382 |
Income (loss) before income taxes |  |  | 710 |  |  |  | (922 | ) |  |  | 1,654 |  |  |  | 355 |  |  |  | (728 | ) |  |  | 1,069 |
Provision (benefit) for income taxes |  |  | (49 | ) |  |  | (214 | ) |  |  | 379 |  |  |  | 57 |  |  |  | — |  |  |  | 173 |
Net income (loss) |  |  | 759 |  |  |  | (708 | ) |  |  | 1,275 |  |  |  | 298 |  |  |  | (728 | ) |  |  | 896 |
Net income attributable to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | 22 |  |  |  | 115 |  |  |  | — |  |  |  | 137 |
Net income (loss) attributable to HCA Healthcare, Inc. |  | $ | 759 |  |  | $ | (708 | ) |  | $ | 1,253 |  |  | $ | 183 |  |  | $ | (728 | ) |  | $ | 759 |
Comprehensive income (loss) attributable to HCA Healthcare, Inc. |  | $ | 754 |  |  | $ | (703 | ) |  | $ | 1,258 |  |  | $ | 168 |  |  | $ | (723 | ) |  | $ | 754 |
HCA HEALTHCARE, INC. CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT FOR THE QUARTER ENDED SEPTEMBER 30, 2017 (Dollars in millions)
|  | HCA Healthcare, Inc. Issuer |  |  | HCA Inc. Issuer |  |  | Subsidiary Guarantors (as adjusted) |  |  | Subsidiary Non- Guarantors (as adjusted) |  |  | Eliminations |  |  | Condensed Consolidated |
Revenues |  | $ | — |  |  | $ | — |  |  | $ | 6,303 |  |  | $ | 4,393 |  |  | $ | — |  |  | $ | 10,696 |
Salaries and benefits |  |  | — |  |  |  | — |  |  |  | 2,915 |  |  |  | 2,166 |  |  |  | — |  |  |  | 5,081 |
Supplies |  |  | — |  |  |  | — |  |  |  | 1,033 |  |  |  | 744 |  |  |  | — |  |  |  | 1,777 |
Other operating expenses |  |  | — |  |  |  | — |  |  |  | 1,093 |  |  |  | 982 |  |  |  | — |  |  |  | 2,075 |
Equity in earnings of affiliates |  |  | (436 | ) |  |  | — |  |  |  | (1 | ) |  |  | (12 | ) |  |  | 436 |  |  |  | (13 | )
Depreciation and amortization |  |  | — |  |  |  | — |  |  |  | 311 |  |  |  | 228 |  |  |  | — |  |  |  | 539 |
Interest expense (income) |  |  | 16 |  |  |  | 792 |  |  |  | (342 | ) |  |  | (39 | ) |  |  | — |  |  |  | 427 |
Gains on sales of facilities |  |  | — |  |  |  | — |  |  |  | (3 | ) |  |  | (4 | ) |  |  | — |  |  |  | (7 | )
Losses on retirement of debt |  |  | — |  |  |  | 39 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 39 |
Management fees |  |  | — |  |  |  | — |  |  |  | (159 | ) |  |  | 159 |  |  |  | — |  |  |  | — |
|  |  | (420 | ) |  |  | 831 |  |  |  | 4,847 |  |  |  | 4,224 |  |  |  | 436 |  |  |  | 9,918 |
Income (loss) before income taxes |  |  | 420 |  |  |  | (831 | ) |  |  | 1,456 |  |  |  | 169 |  |  |  | (436 | ) |  |  | 778 |
Provision (benefit) for income taxes |  |  | (6 | ) |  |  | (307 | ) |  |  | 528 |  |  |  | 33 |  |  |  | — |  |  |  | 248 |
Net income (loss) |  |  | 426 |  |  |  | (524 | ) |  |  | 928 |  |  |  | 136 |  |  |  | (436 | ) |  |  | 530 |
Net income attributable to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | 24 |  |  |  | 80 |  |  |  | — |  |  |  | 104 |
Net income (loss) attributable to HCA Healthcare, Inc. |  | $ | 426 |  |  | $ | (524 | ) |  | $ | 904 |  |  | $ | 56 |  |  | $ | (436 | ) |  | $ | 426 |
Comprehensive income (loss) attributable to HCA Healthcare, Inc. |  | $ | 451 |  |  | $ | (522 | ) |  | $ | 907 |  |  | $ | 76 |  |  | $ | (461 | ) |  | $ | 451 |
HCA HEALTHCARE, INC. CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018 (Dollars in millions)
|  | HCA Healthcare, Inc. Issuer |  |  | HCA Inc. Issuer |  |  | Subsidiary Guarantors |  |  | Subsidiary Non- Guarantors |  |  | Eliminations |  |  | Condensed Consolidated |
Revenues |  | $ | — |  |  | $ | — |  |  | $ | 20,297 |  |  | $ | 14,106 |  |  | $ | — |  |  | $ | 34,403 |
Salaries and benefits |  |  | — |  |  |  | — |  |  |  | 9,184 |  |  |  | 6,756 |  |  |  | — |  |  |  | 15,940 |
Supplies |  |  | — |  |  |  | — |  |  |  | 3,383 |  |  |  | 2,339 |  |  |  | — |  |  |  | 5,722 |
Other operating expenses |  |  | 7 |  |  |  | — |  |  |  | 3,387 |  |  |  | 2,931 |  |  |  | — |  |  |  | 6,325 |
Equity in earnings of affiliates |  |  | (2,670 | ) |  |  | — |  |  |  | (5 | ) |  |  | (20 | ) |  |  | 2,670 |  |  |  | (25 | )
Depreciation and amortization |  |  | — |  |  |  | — |  |  |  | 992 |  |  |  | 705 |  |  |  | — |  |  |  | 1,697 |
Interest expense (income) |  |  | 48 |  |  |  | 2,617 |  |  |  | (1,179 | ) |  |  | (177 | ) |  |  | — |  |  |  | 1,309 |
Gains on sales of facilities |  |  | — |  |  |  | — |  |  |  | (378 | ) |  |  | (42 | ) |  |  | — |  |  |  | (420 | )
Losses on retirement of debt |  |  | — |  |  |  | 9 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 9 |
Management fees |  |  | — |  |  |  | — |  |  |  | (473 | ) |  |  | 473 |  |  |  | — |  |  |  | — |
|  |  | (2,615 | ) |  |  | 2,626 |  |  |  | 14,911 |  |  |  | 12,965 |  |  |  | 2,670 |  |  |  | 30,557 |
Income (loss) before income taxes |  |  | 2,615 |  |  |  | (2,626 | ) |  |  | 5,386 |  |  |  | 1,141 |  |  |  | (2,670 | ) |  |  | 3,846 |
Provision (benefit) for income taxes |  |  | (108 | ) |  |  | (610 | ) |  |  | 1,235 |  |  |  | 185 |  |  |  | — |  |  |  | 702 |
Net income (loss) |  |  | 2,723 |  |  |  | (2,016 | ) |  |  | 4,151 |  |  |  | 956 |  |  |  | (2,670 | ) |  |  | 3,144 |
Net income attributable to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | 72 |  |  |  | 349 |  |  |  | — |  |  |  | 421 |
Net income (loss) attributable to HCA Healthcare, Inc. |  | $ | 2,723 |  |  | $ | (2,016 | ) |  | $ | 4,079 |  |  | $ | 607 |  |  | $ | (2,670 | ) |  | $ | 2,723 |
Comprehensive income (loss) attributable to HCA Healthcare, Inc. |  | $ | 2,735 |  |  | $ | (1,974 | ) |  | $ | 4,091 |  |  | $ | 565 |  |  | $ | (2,682 | ) |  | $ | 2,735 |
HCA HEALTHCARE, INC. CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017 (Dollars in millions)
|  | HCA Healthcare, Inc. Issuer |  |  | HCA Inc. Issuer |  |  | Subsidiary Guarantors (as adjusted) |  |  | Subsidiary Non- Guarantors (as adjusted) |  |  | Eliminations |  |  | Condensed Consolidated |
Revenues |  | $ | — |  |  | $ | — |  |  | $ | 19,008 |  |  | $ | 13,044 |  |  | $ | — |  |  | $ | 32,052 |
Salaries and benefits |  |  | — |  |  |  | — |  |  |  | 8,689 |  |  |  | 6,189 |  |  |  | — |  |  |  | 14,878 |
Supplies |  |  | — |  |  |  | — |  |  |  | 3,163 |  |  |  | 2,206 |  |  |  | — |  |  |  | 5,369 |
Other operating expenses |  |  | 5 |  |  |  | — |  |  |  | 3,207 |  |  |  | 2,758 |  |  |  | — |  |  |  | 5,970 |
Equity in earnings of affiliates |  |  | (1,702 | ) |  |  | — |  |  |  | (4 | ) |  |  | (32 | ) |  |  | 1,702 |  |  |  | (36 | )
Depreciation and amortization |  |  | — |  |  |  | — |  |  |  | 923 |  |  |  | 658 |  |  |  | — |  |  |  | 1,581 |
Interest expense (income) |  |  | 48 |  |  |  | 2,280 |  |  |  | (947 | ) |  |  | (124 | ) |  |  | — |  |  |  | 1,257 |
Gains on sales of facilities |  |  | — |  |  |  | — |  |  |  | (6 | ) |  |  | (4 | ) |  |  | — |  |  |  | (10 | )
Losses on retirement of debt |  |  | — |  |  |  | 39 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 39 |
Management fees |  |  | — |  |  |  | — |  |  |  | (479 | ) |  |  | 479 |  |  |  | — |  |  |  | — |
|  |  | (1,649 | ) |  |  | 2,319 |  |  |  | 14,546 |  |  |  | 12,130 |  |  |  | 1,702 |  |  |  | 29,048 |
Income (loss) before income taxes |  |  | 1,649 |  |  |  | (2,319 | ) |  |  | 4,462 |  |  |  | 914 |  |  |  | (1,702 | ) |  |  | 3,004 |
Provision (benefit) for income taxes |  |  | (93 | ) |  |  | (856 | ) |  |  | 1,619 |  |  |  | 232 |  |  |  | — |  |  |  | 902 |
Net income (loss) |  |  | 1,742 |  |  |  | (1,463 | ) |  |  | 2,843 |  |  |  | 682 |  |  |  | (1,702 | ) |  |  | 2,102 |
Net income attributable to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | 74 |  |  |  | 286 |  |  |  | — |  |  |  | 360 |
Net income (loss) attributable to HCA Healthcare, Inc. |  | $ | 1,742 |  |  | $ | (1,463 | ) |  | $ | 2,769 |  |  | $ | 396 |  |  | $ | (1,702 | ) |  | $ | 1,742 |
Comprehensive income (loss) attributable to HCA Healthcare, Inc. |  | $ | 1,812 |  |  | $ | (1,458 | ) |  | $ | 2,778 |  |  | $ | 452 |  |  | $ | (1,772 | ) |  | $ | 1,812 |
HCA HEALTHCARE, INC. CONDENSED CONSOLIDATING BALANCE SHEET SEPTEMBER 30, 2018 (Dollars in millions)
|  | HCA Healthcare, Inc. Issuer |  |  | HCA Inc. Issuer |  |  | Subsidiary Guarantors |  |  | Subsidiary Non- Guarantors |  |  | Eliminations |  |  | Condensed Consolidated |
ASSETS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | — |  |  | $ | — |  |  | $ | 105 |  |  | $ | 473 |  |  | $ | — |  |  | $ | 578 |
Accounts receivable |  |  | — |  |  |  | — |  |  |  | 3,854 |  |  |  | 2,678 |  |  |  | — |  |  |  | 6,532 |
Inventories |  |  | — |  |  |  | — |  |  |  | 1,088 |  |  |  | 546 |  |  |  | — |  |  |  | 1,634 |
Other |  |  | 47 |  |  |  | — |  |  |  | 667 |  |  |  | 552 |  |  |  | — |  |  |  | 1,266 |
|  |  | 47 |  |  |  | — |  |  |  | 5,714 |  |  |  | 4,249 |  |  |  | — |  |  |  | 10,010 |
Property and equipment, net |  |  | — |  |  |  | — |  |  |  | 12,192 |  |  |  | 6,849 |  |  |  | — |  |  |  | 19,041 |
Investments of insurance subsidiaries |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 367 |  |  |  | — |  |  |  | 367 |
Investments in and advances to affiliates |  |  | 32,263 |  |  |  | — |  |  |  | 29 |  |  |  | 209 |  |  |  | (32,263 | ) |  |  | 238 |
Goodwill and other intangible assets |  |  | — |  |  |  | — |  |  |  | 5,736 |  |  |  | 2,023 |  |  |  | — |  |  |  | 7,759 |
Other |  |  | 389 |  |  |  | 106 |  |  |  | 29 |  |  |  | 105 |  |  |  | — |  |  |  | 629 |
|  | $ | 32,699 |  |  | $ | 106 |  |  | $ | 23,700 |  |  | $ | 13,802 |  |  | $ | (32,263 | ) |  | $ | 38,044 |
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | — |  |  | $ | — |  |  | $ | 1,627 |  |  | $ | 787 |  |  | $ | — |  |  | $ | 2,414 |
Accrued salaries |  |  | — |  |  |  | — |  |  |  | 914 |  |  |  | 542 |  |  |  | — |  |  |  | 1,456 |
Other accrued expenses |  |  | 10 |  |  |  | 296 |  |  |  | 790 |  |  |  | 1,074 |  |  |  | — |  |  |  | 2,170 |
Long-term debt due within one year |  |  | — |  |  |  | 97 |  |  |  | 61 |  |  |  | 33 |  |  |  | — |  |  |  | 191 |
|  |  | 10 |  |  |  | 393 |  |  |  | 3,392 |  |  |  | 2,436 |  |  |  | — |  |  |  | 6,231 |
Long-term debt, net |  |  | 996 |  |  |  | 31,471 |  |  |  | 281 |  |  |  | 168 |  |  |  | — |  |  |  | 32,916 |
Intercompany balances |  |  | 36,790 |  |  |  | (7,734 | ) |  |  | (27,263 | ) |  |  | (1,793 | ) |  |  | — |  |  |  | — |
Professional liability risks |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,239 |  |  |  | — |  |  |  | 1,239 |
Income taxes and other liabilities |  |  | 508 |  |  |  | — |  |  |  | 364 |  |  |  | 516 |  |  |  | — |  |  |  | 1,388 |
|  |  | 38,304 |  |  |  | 24,130 |  |  |  | (23,226 | ) |  |  | 2,566 |  |  |  | — |  |  |  | 41,774 |
Stockholders’ (deficit) equity attributable to HCA Healthcare, Inc. |  |  | (5,605 | ) |  |  | (24,024 | ) |  |  | 46,846 |  |  |  | 9,441 |  |  |  | (32,263 | ) |  |  | (5,605 | )
Noncontrolling interests |  |  | — |  |  |  | — |  |  |  | 80 |  |  |  | 1,795 |  |  |  | — |  |  |  | 1,875 |
|  |  | (5,605 | ) |  |  | (24,024 | ) |  |  | 46,926 |  |  |  | 11,236 |  |  |  | (32,263 | ) |  |  | (3,730 | )
|  | $ | 32,699 |  |  | $ | 106 |  |  | $ | 23,700 |  |  | $ | 13,802 |  |  | $ | (32,263 | ) |  | $ | 38,044 |
HCA HEALTHCARE, INC. CONDENSED CONSOLIDATING BALANCE SHEET DECEMBER 31, 2017 (Dollars in millions)
|  | HCA Healthcare, Inc. Issuer |  |  | HCA Inc. Issuer |  |  | Subsidiary Guarantors |  |  | Subsidiary Non- Guarantors |  |  | Eliminations |  |  | Condensed Consolidated |
ASSETS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 1 |  |  | $ | — |  |  | $ | 112 |  |  | $ | 619 |  |  | $ | — |  |  | $ | 732 |
Accounts receivable |  |  | — |  |  |  | — |  |  |  | 3,693 |  |  |  | 2,808 |  |  |  | — |  |  |  | 6,501 |
Inventories |  |  | — |  |  |  | — |  |  |  | 1,030 |  |  |  | 543 |  |  |  | — |  |  |  | 1,573 |
Other |  |  | — |  |  |  | — |  |  |  | 663 |  |  |  | 508 |  |  |  | — |  |  |  | 1,171 |
|  |  | 1 |  |  |  | — |  |  |  | 5,498 |  |  |  | 4,478 |  |  |  | — |  |  |  | 9,977 |
Property and equipment, net |  |  | — |  |  |  | — |  |  |  | 11,110 |  |  |  | 6,785 |  |  |  | — |  |  |  | 17,895 |
Investments of insurance subsidiaries |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 418 |  |  |  | — |  |  |  | 418 |
Investments in and advances to affiliates |  |  | 29,581 |  |  |  | — |  |  |  | 22 |  |  |  | 177 |  |  |  | (29,581 | ) |  |  | 199 |
Goodwill and other intangible assets |  |  | — |  |  |  | — |  |  |  | 4,893 |  |  |  | 2,501 |  |  |  | — |  |  |  | 7,394 |
Other |  |  | 510 |  |  |  | 50 |  |  |  | 47 |  |  |  | 103 |  |  |  | — |  |  |  | 710 |
|  | $ | 30,092 |  |  | $ | 50 |  |  | $ | 21,570 |  |  | $ | 14,462 |  |  | $ | (29,581 | ) |  | $ | 36,593 |
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | — |  |  | $ | — |  |  | $ | 1,793 |  |  | $ | 813 |  |  | $ | — |  |  | $ | 2,606 |
Accrued salaries |  |  | — |  |  |  | — |  |  |  | 862 |  |  |  | 507 |  |  |  | — |  |  |  | 1,369 |
Other accrued expenses |  |  | 29 |  |  |  | 378 |  |  |  | 536 |  |  |  | 1,040 |  |  |  | — |  |  |  | 1,983 |
Long-term debt due within one year |  |  | — |  |  |  | 97 |  |  |  | 64 |  |  |  | 39 |  |  |  | — |  |  |  | 200 |
|  |  | 29 |  |  |  | 475 |  |  |  | 3,255 |  |  |  | 2,399 |  |  |  | — |  |  |  | 6,158 |
Long-term debt, net |  |  | 995 |  |  |  | 31,367 |  |  |  | 307 |  |  |  | 189 |  |  |  | — |  |  |  | 32,858 |
Intercompany balances |  |  | 35,322 |  |  |  | (9,742 | ) |  |  | (25,228 | ) |  |  | (352 | ) |  |  | — |  |  |  | — |
Professional liability risks |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,198 |  |  |  | — |  |  |  | 1,198 |
Income taxes and other liabilities |  |  | 552 |  |  |  | — |  |  |  | 357 |  |  |  | 465 |  |  |  | — |  |  |  | 1,374 |
|  |  | 36,898 |  |  |  | 22,100 |  |  |  | (21,309) |  |  |  | 3,899 |  |  |  | — |  |  |  | 41,588 |
Stockholders’ (deficit) equity attributable to HCA Healthcare, Inc. |  |  | (6,806 | ) |  |  | (22,050 | ) |  |  | 42,755 |  |  |  | 8,876 |  |  |  | (29,581 | ) |  |  | (6,806 | )
Noncontrolling interests |  |  | — |  |  |  | — |  |  |  | 124 |  |  |  | 1,687 |  |  |  | — |  |  |  | 1,811 |
|  |  | (6,806 | ) |  |  | (22,050 | ) |  |  | 42,879 |  |  |  | 10,563 |  |  |  | (29,581 | ) |  |  | (4,995 | )
|  | $ | 30,092 |  |  | $ | 50 |  |  | $ | 21,570 |  |  | $ | 14,462 |  |  | $ | (29,581 | ) |  | $ | 36,593 |
HCA HEALTHCARE, INC. CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2018 (Dollars in millions)
|  | HCA Healthcare, Inc. Issuer |  |  | HCA Inc. Issuer |  |  | Subsidiary Guarantors |  |  | Subsidiary Non- Guarantors |  |  | Eliminations |  |  | Condensed Consolidated |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 2,723 |  |  | $ | (2,016 | ) |  | $ | 4,151 |  |  | $ | 956 |  |  | $ | (2,670 | ) |  | $ | 3,144 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Changes in operating assets and liabilities |  |  | (15 | ) |  |  | (83 | ) |  |  | (154 | ) |  |  | 105 |  |  |  | — |  |  |  | (147 | )
Depreciation and amortization |  |  | — |  |  |  | — |  |  |  | 992 |  |  |  | 705 |  |  |  | — |  |  |  | 1,697 |
Gains on sales of facilities |  |  | — |  |  |  | — |  |  |  | (378 | ) |  |  | (42 | ) |  |  | — |  |  |  | (420 | )
Losses on retirement of debt |  |  | — |  |  |  | 9 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 9 |
Amortization of debt issuance costs |  |  | — |  |  |  | 23 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 23 |
Share-based compensation |  |  | — |  |  |  | — |  |  |  | 204 |  |  |  | — |  |  |  | — |  |  |  | 204 |
Equity in earnings of affiliates |  |  | (2,670 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2,670 |  |  |  | — |
Other |  |  | 67 |  |  |  | — |  |  |  | — |  |  |  | 9 |  |  |  | — |  |  |  | 76 |
Net cash provided by (used in) operating activities |  |  | 105 |  |  |  | (2,067 | ) |  |  | 4,815 |  |  |  | 1,733 |  |  |  | — |  |  |  | 4,586 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | — |  |  |  | — |  |  |  | (1,425 | ) |  |  | (995 | ) |  |  | — |  |  |  | (2,420 | )
Acquisition of hospitals and health care entities |  |  | — |  |  |  | — |  |  |  | (894 | ) |  |  | (162 | ) |  |  | — |  |  |  | (1,056 | )
Disposition of hospitals and health care entities |  |  | — |  |  |  | — |  |  |  | 770 |  |  |  | 32 |  |  |  | — |  |  |  | 802 |
Change in investments |  |  | — |  |  |  | — |  |  |  | 19 |  |  |  | 46 |  |  |  | — |  |  |  | 65 |
Other |  |  | — |  |  |  | — |  |  |  | (18 | ) |  |  | 12 |  |  |  | — |  |  |  | (6 | )
Net cash used in investing activities |  |  | — |  |  |  | — |  |  |  | (1,548 | ) |  |  | (1,067 | ) |  |  | — |  |  |  | (2,615 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of long-term debt |  |  | — |  |  |  | 2,000 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2,000 |
Net change in revolving credit facilities |  |  | — |  |  |  | (330 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (330 | )
Repayment of long-term debt |  |  | — |  |  |  | (1,566 | ) |  |  | (44 | ) |  |  | (42 | ) |  |  | — |  |  |  | (1,652 | )
Distributions to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | (63 | ) |  |  | (252 | ) |  |  | — |  |  |  | (315 | )
Payment of debt issuance costs |  |  | — |  |  |  | (24 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (24 | )
Payment of cash dividends |  |  | (366 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (366 | )
Repurchases of common stock |  |  | (1,195 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1,195 | )
Changes in intercompany balances with affiliates, net |  |  | 1,697 |  |  |  | 1,987 |  |  |  | (3,167 | ) |  |  | (517 | ) |  |  | — |  |  |  | — |
Other |  |  | (242 | ) |  |  | — |  |  |  | — |  |  |  | 10 |  |  |  | — |  |  |  | (232 | )
Net cash (used in) provided by financing activities |  |  | (106 | ) |  |  | 2,067 |  |  |  | (3,274 | ) |  |  | (801 | ) |  |  | — |  |  |  | (2,114 | )
Effect on exchange rate changes on cash and cash equivalents |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (11 | ) |  |  | — |  |  |  | (11 | )
Change in cash and cash equivalents |  |  | (1 | ) |  |  | — |  |  |  | (7 | ) |  |  | (146 | ) |  |  | — |  |  |  | (154 | )
Cash and cash equivalents at beginning of period |  |  | 1 |  |  |  | — |  |  |  | 112 |  |  |  | 619 |  |  |  | — |  |  |  | 732 |
Cash and cash equivalents at end of period |  | $ | — |  |  | $ | — |  |  | $ | 105 |  |  | $ | 473 |  |  | $ | — |  |  | $ | 578 |
HCA HEALTHCARE, INC. CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2017 (Dollars in millions)
|  | HCA Healthcare, Inc. Issuer |  |  | HCA Inc. Issuer |  |  | Subsidiary Guarantors (as adjusted) |  |  | Subsidiary Non- Guarantors (as adjusted) |  |  | Eliminations |  |  | Condensed Consolidated |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 1,742 |  |  | $ | (1,463 | ) |  | $ | 2,843 |  |  | $ | 682 |  |  | $ | (1,702 | ) |  | $ | 2,102 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Changes in operating assets and liabilities |  |  | (15 | ) |  |  | (293 | ) |  |  | (191 | ) |  |  | 210 |  |  |  | — |  |  |  | (289 | )
Depreciation and amortization |  |  | — |  |  |  | — |  |  |  | 923 |  |  |  | 658 |  |  |  | — |  |  |  | 1,581 |
Income taxes |  |  | (9 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (9 | )
Gains on sales of facilities |  |  | — |  |  |  | — |  |  |  | (6 | ) |  |  | (4 | ) |  |  | — |  |  |  | (10 | )
Losses on retirement of debt |  |  | — |  |  |  | 39 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 39 |
Amortization of debt issuance costs |  |  | — |  |  |  | 23 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 23 |
Share-based compensation |  |  | — |  |  |  | — |  |  |  | 195 |  |  |  | — |  |  |  | — |  |  |  | 195 |
Equity in earnings of affiliates |  |  | (1,702 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,702 |  |  |  | — |
Other |  |  | 58 |  |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | — |  |  |  | 60 |
Net cash provided by (used in) operating activities |  |  | 74 |  |  |  | (1,694 | ) |  |  | 3,766 |  |  |  | 1,546 |  |  |  | — |  |  |  | 3,692 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of property and equipment |  |  | — |  |  |  | — |  |  |  | (1,161 | ) |  |  | (872 | ) |  |  | — |  |  |  | (2,033 | )
Acquisition of hospitals and health care entities |  |  | — |  |  |  | — |  |  |  | (9 | ) |  |  | (1,133 | ) |  |  | — |  |  |  | (1,142 | )
Disposition of hospitals and health care entities |  |  | — |  |  |  | — |  |  |  | 12 |  |  |  | 12 |  |  |  | — |  |  |  | 24 |
Change in investments |  |  | — |  |  |  | — |  |  |  | 1 |  |  |  | (16 | ) |  |  | — |  |  |  | (15 | )
Other |  |  | — |  |  |  | — |  |  |  | (7 | ) |  |  | 1 |  |  |  | — |  |  |  | (6 | )
Net cash used in investing activities |  |  | — |  |  |  | — |  |  |  | (1,164 | ) |  |  | (2,008 | ) |  |  | — |  |  |  | (3,172 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of long-term debt |  |  | — |  |  |  | 1,500 |  |  |  | — |  |  |  | 2 |  |  |  | — |  |  |  | 1,502 |
Net change in revolving credit facilities |  |  | — |  |  |  | 650 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 650 |
Repayment of long-term debt |  |  | — |  |  |  | (604 | ) |  |  | (54 | ) |  |  | (42 | ) |  |  | — |  |  |  | (700 | )
Distributions to noncontrolling interests |  |  | — |  |  |  | — |  |  |  | (105 | ) |  |  | (258 | ) |  |  | — |  |  |  | (363 | )
Payment of debt issuance costs |  |  | — |  |  |  | (25 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (25 | )
Repurchases of common stock |  |  | (1,475 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1,475 | )
Changes in intercompany balances with affiliates, net |  |  | 1,468 |  |  |  | 173 |  |  |  | (2,439 | ) |  |  | 798 |  |  |  | — |  |  |  | — |
Other |  |  | (66 | ) |  |  | — |  |  |  | 1 |  |  |  | 28 |  |  |  | — |  |  |  | (37 | )
Net cash (used in) provided by financing activities |  |  | (73 | ) |  |  | 1,694 |  |  |  | (2,597 | ) |  |  | 528 |  |  |  | — |  |  |  | (448 | )
Change in cash and cash equivalents |  |  | 1 |  |  |  | — |  |  |  | 5 |  |  |  | 66 |  |  |  | — |  |  |  | 72 |
Cash and cash equivalents at beginning of period |  |  | — |  |  |  | — |  |  |  | 114 |  |  |  | 532 |  |  |  | — |  |  |  | 646 |
Cash and cash equivalents at end of period |  | $ | 1 |  |  | $ | — |  |  | $ | 119 |  |  | $ | 598 |  |  | $ | — |  |  | $ | 718 |
The above supplemental condensed consolidating financial information for the quarter and nine months ended September 30, 2017 has been adjusted to properly record the impact of certain subsidiaries that were non-guarantors becoming guarantors, primarily related to the Company acquiring previous noncontrolling interests of non-guarantor subsidiaries that then became guarantor subsidiaries. The impact of these adjustments was immaterial as they had no impact to our consolidated income statements, balance sheets or statements of cash flows, had no impact on any liquidity measures of the Company, nor did they impact any financial ratios based on our consolidated balance sheets or income statements. There was also no impact to our loan covenant reporting or compliance. The impact of the adjustments was limited to reclassifications between the Subsidiary Guarantors and Subsidiary Non-Guarantors columns of the condensed consolidating financial statements. The application of these adjustments to the consolidating information for the quarter and nine months ended September 30, 2017 is summarized as follows (dollars in millions):
|  | As Previously Reported |  |  | Adjustment |  |  | As Adjusted |
Quarter ended September 30, 2017 |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) attributable to HCA Healthcare, Inc.: |  |  |  |  |  |  |  |  |  |  |  |
HCA Healthcare, Inc. Issuer |  | $ | 426 |  |  | $ | — |  |  | $ | 426 |
HCA Inc. Issuer |  |  | (524 | ) |  |  | — |  |  |  | (524 | )
Subsidiary Guarantors |  |  | 787 |  |  |  | 117 |  |  |  | 904 |
Subsidiary Non-Guarantors |  |  | 173 |  |  |  | (117 | ) |  |  | 56 |
Eliminations |  |  | (436 | ) |  |  | — |  |  |  | (436 | )
Condensed Consolidated |  | $ | 426 |  |  | $ | — |  |  | $ | 426 |
|  | As Previously Reported |  |  | Adjustment |  |  | As Adjusted |
Nine months ended September 30, 2017 |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) attributable to HCA Healthcare, Inc.: |  |  |  |  |  |  |  |  |  |  |  |
HCA Healthcare, Inc. Issuer |  | $ | 1,742 |  |  | $ | — |  |  | $ | 1,742 |
HCA Inc. Issuer |  |  | (1,463 | ) |  |  | — |  |  |  | (1,463 | )
Subsidiary Guarantors |  |  | 2,467 |  |  |  | 302 |  |  |  | 2,769 |
Subsidiary Non-Guarantors |  |  | 698 |  |  |  | (302 | ) |  |  | 396 |
Eliminations |  |  | (1,702 | ) |  |  | — |  |  |  | (1,702 | )
Condensed Consolidated |  | $ | 1,742 |  |  | $ | — |  |  | $ | 1,742 |
|  | As Previously Reported |  |  | Adjustment |  |  | As Adjusted |
Nine months ended September 30, 2017 |  |  |  |  |  |  |  |  |  |  |  |
Net cash provided (used in) operating activities: |  |  |  |  |  |  |  |  |  |  |  |
HCA Healthcare, Inc. Issuer |  | $ | 74 |  |  | $ | — |  |  | $ | 74 |
HCA Inc. Issuer |  |  | (1,694 | ) |  |  | — |  |  |  | (1,694 | )
Subsidiary Guarantors |  |  | 3,342 |  |  |  | 424 |  |  |  | 3,766 |
Subsidiary Non-Guarantors |  |  | 1,970 |  |  |  | (424 | ) |  |  | 1,546 |
Eliminations |  |  | — |  |  |  | — |  |  |  | — |
Condensed Consolidated |  | $ | 3,692 |  |  | $ | — |  |  | $ | 3,692 |

X
- Definition The entire disclosure for condensed financial statements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph d -Subparagraph 4 -Subsection 10 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph c -Subparagraph 4 -Subsection 10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph a -Subsection 04 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph e -Subparagraph 4 -Subsection 10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph f -Subparagraph 4 -Subsection 10 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 + Details
Name: | srt_CondensedFinancialStatementsTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration